You left out 16M from podiatry, 12M from neurology. He didn’t give a number for pharma but that’s gonna be huge. HMO/MSO planning to begin in first two Q of next year. NGIO spinout hopefully by end of this month.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
